Autologous or allogeneic hematopoietic stem cell transplantation occupies an important position in the comprehensive treatment of aggressive lymphoma, and there is no exception for nasal type extranodal NK/T cell lymphoma. According to the domestic and international literature reports and the actual situation of our treated patients, it is suggested that hematopoietic stem cell transplantation should be taken positively for patients with nasal-type extranodal NK/T-cell lymphoma, and autologous hematopoietic stem cell transplantation should be considered firstly for stage I patients with poor prognostic factors and stage II patients, and allogeneic hematopoietic stem cell transplantation should be considered as early as possible for stage III, stage IV, and relapsed/refractory patients, although there are cases of successful transplantation in second Although there are cases of successful transplantation during the second complete remission, it is better to try to transplant during the first complete remission.